# Triton Technology Fund

> Triton Technology Fund is a VC fund in San Diego backing Biotechnology and Nanotechnology. See 6 investments, round sizes, portfolio. Updated Oct 2026.

- Type: VC Fund
- Location: San Diego, United States
- Total investments: 6
- Last investment: Jan 2018
- Lead investor: 17%
- Last updated: Oct 2026

Triton Technology Fund is a seed stage investment fund specializes in healthcare, software, and communications industry.

## Investment focus

### Industry

| Industry | Investments | Share |
| --- | --- | --- |
| Biotechnology | 3 | 50% |
| Nanotechnology | 2 | 33% |
| Health Diagnostics | 2 | 33% |
| Sensor | 1 | 17% |
| Medical | 1 | 17% |

9 industries tracked in total.

### Stage

| Stage | Investments | Share |
| --- | --- | --- |
| Seed | 3 | 50% |
| Series A | 1 | 17% |
| Debt Financing | 1 | 17% |
| Venture - Series Unknown | 1 | 17% |

## Investments

| Company | Description | Amount | Stage | Date | Website |
| --- | --- | --- | --- | --- | --- |
| NanoCellect Biomedical | NanoCellect Biomedical, Inc. aims to make flow cytometry and cell sorting technology more affordable and accessible for life science researchers to perform cellular analysis, develop molecular diagnostics, and improve personalized medicine.A critical element for biomedical research is the ability for scientists to analyze and isolate cellsusing flow cytometers. Scientists use flow cytometers to obtain a fast, objective and quantitative recording of fluorescent signals from individual cells as well as physical separation of cells of particular interest.NanoCellect's mission is to facilitate breakthrough biomedical discoveries by making cell analysis and sorting technology more portable, affordable, and easier to use. We use microfluidics to make flow cytometers that enable biomedical scientists to analyze and sort cells required for drug discovery, diagnostics, or basic research. | $250K | Venture - Series Unknown | Jan 12, 2018 | http://nanocellect.com/ |
| Abreos Biosciences | Abreos Biosciences develops lateral flow assays that measure the activity of high-value biologics. Its simple devices can be used for quality assurance, pharmacokinetic monitoring, and authentication in field, forensic, or point of care settings. We deliver value by enhancing brand protection, improving patients’ outcomes, and enabling rapidauthentication for counterfeit prevention and end-user confidence. The company was founded in 2013 and headquartered in San Diego, California. | $1.2M | Debt Financing | Jun 05, 2017 | http://abreos.com/ |
| Abreos Biosciences | Abreos Biosciences develops lateral flow assays that measure the activity of high-value biologics. Its simple devices can be used for quality assurance, pharmacokinetic monitoring, and authentication in field, forensic, or point of care settings. We deliver value by enhancing brand protection, improving patients’ outcomes, and enabling rapidauthentication for counterfeit prevention and end-user confidence. The company was founded in 2013 and headquartered in San Diego, California. | $725K | Seed | Jul 13, 2016 | http://abreos.com/ |
| Grolltex, Inc. | Grolltex, for 'graphene-rolling-technology', is an advanced materials and biosensor company with patent protected processes enabling 1) The mass production of high quality, CVD generated 'sheet' graphene at scalable, manufacturing friendly prices, and 2) The design and production of single atomic layer biosensors capable ofadvanced life science applications in genomics, antigen and molecular detection, glucose and allergen sensing and many other areas. . The company's novel concept of 'metal assisted exfoliation' significantly lowers costs for the type of large area, mono-layer graphene needed for electronics manufacturing, finally taking graphene out of the lab and moving it into practical application. This process solves the CVD generated graphene 'transfer issue' by removing graphene from the previously sacrificial copper substrate without destroying the copper, putting that same copper right back into the production line. Additionally, this methodology uses conventional thin film tools and processes that exist in industry today. | $1M | Seed | Apr 03, 2016 | https://grolltex.com |
| Manta Instruments | MANTA Instruments Inc. (MANTA) is commercializing scientific instruments that use breakthrough technology to characterize nanoparticles much more effectively than existing products. Existing instruments for characterizing nanoparticles are unable to: i) adequately measure concentration of nanoparticles, ii) measure samples with mixednanoparticle sizes, and iii) reliably measure changes in nanoparticle size over time. |  | Series A | Dec 10, 2015 | http://www.mantainc.com/ |
| Manta Instruments | MANTA Instruments Inc. (MANTA) is commercializing scientific instruments that use breakthrough technology to characterize nanoparticles much more effectively than existing products. Existing instruments for characterizing nanoparticles are unable to: i) adequately measure concentration of nanoparticles, ii) measure samples with mixednanoparticle sizes, and iii) reliably measure changes in nanoparticle size over time. |  | Seed | May 28, 2015 | http://www.mantainc.com/ |

6 of 6 investments shown.

## Co-investors
- Highlander Venture Fund — VC Fund, 1 deal together
- [Illumina Ventures](https://shizune.co/investors/profile/illumina-ventures) — VC Fund, 1 deal together
- [Joint Polish Investment Fund](https://shizune.co/investors/profile/joint-polish-investment-fund) — VC Fund, 1 deal together
- Rady Venture Fund — VC Fund, 1 deal together
- TLP Investment Partners — VC Fund, 1 deal together
- [Vertical Venture Partners](https://shizune.co/investors/profile/vertical-venture-partners) — VC Fund, 1 deal together

## Similar investors

### Similar stage
- [Antler](https://shizune.co/investors/profile/antler-be9c) — VC Fund
- [Right Side Capital Management](https://shizune.co/investors/profile/right-side-capital-management) — VC Fund
- [Alumni Ventures](https://shizune.co/investors/profile/alumni-ventures-group) — VC Fund

## FAQ

### What does Triton Technology Fund invest in?

Triton Technology Fund invests primarily in Biotechnology, Nanotechnology and Health Diagnostics startups, most often at Seed and Series A stage. Most of the 6 investments tracked by Shizune back companies in United States. The Investment Focus section breaks down every industry, stage and country in the portfolio.

### When did Triton Technology Fund last invest?

The most recent investment recorded for Triton Technology Fund closed in Jan 2018. Shizune tracks 6 investments in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly.

### Is Shizune's investor data accurate?

Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Oct 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.

# About Shizune
Shizune.co is an investor database. Core features:
- 48,091 startup investors (angels, VCs, accelerators, and others)
- Email, phone, LinkedIn (for intros), socials, and other contact data
- Updated daily from public funding news
- CSV and Excel export

The User can access the full database FOR FREE after signing up: shizune.co